Showing results (81-90 of 365) with videos related to
Sort By:
Pageof 37
Immunotargets and Therapy|April 1, 2017
Phase I clinical trial of sipuleucel-T combined with escalating doses of ipilimumab in progressive metastatic castrate-resistant prostate cancerMark Scholz, Sabrina Yep, Micah Chancey, et al.Immunotargets and Therapy|February 12, 2021
Immune-Checkpoint Inhibitors Combinations in Metastatic NSCLC: New Options on the Horizon?Francesco Passiglia, Maria Lucia Reale, Valeria Cetoretta, et al.Immunotargets and Therapy|April 14, 2025
A Case Series of Anti-Metabotropic Glutamate Receptor 2 Antibody-Related Diseases with Distinct Neurological InvolvementZhanwei Zhang, Xiaolu Deng, Dandan Guo, et al.Immunotargets and Therapy|April 9, 2025
Comprehensive Analyses of Single-Cell and Bulk RNA Sequencing Data From M2 Macrophages to Elucidate the Immune Prognostic Signature in Patients with Gastric Cancer Peritoneal MetastasisQiao Tang, Liang Tang, Xiaofeng Wang, et al.Immunotargets and Therapy|April 2, 2025
Tumor Immunotherapy Targeting B7-H3: From Mechanisms to Clinical ApplicationsYining Guo, Xudong Wang, Chen Zhang, et al.Immunotargets and Therapy|April 23, 2025
Anti-GAD65 Antibodies Related Refractory Epilepsy Successfully Treated with Tocilizumab: A Case Report and Systematic Literature ReviewShimeng Chen, Miriam Kessi, Jielu Tan, et al.Immunotargets and Therapy|May 5, 2025
Cell-Based Therapeutic Strategies for Autoimmune DiseasesFrancisco B Quero, Tays Troncoso-Bravo, Mónica A Farías, et al.Immunotargets and Therapy|June 11, 2025
The Regulatory Network of Transcription Factors in Macrophage PolarizationJie Liu, Mengran Wang, Yong ZhaoImmunotargets and Therapy|May 12, 2025
How to Choose Treatment Regimens for Idiopathic Membranous Nephropathy Patients with PLA2R-Negative: A Single-Center Retrospective Cohort StudyZijian Zhou, Yijing Zou, Ben Ke, et al.Immunotargets and Therapy|July 29, 2021
Cannabis and Autoimmunity: Possible Mechanisms of ActionValeria Giorgi, Daniela Marotto, Alberto Batticciotto, et al.Pageof 37